Physician

Michael C Mcgoldrick, MD

According to 2025 Medicare claims, Michael Mcgoldrick, MD (NPI: 1285749085) practices nephrology in the Bangor, ME market, with the plurality of this provider's patient population coming from Penobscot, ME. This provider's primary affiliated billing organization is NORTHEAST NEPHROLOGY PA (NPI: 1336145200; TIN: 01-0521643) and primary practice location at 04401-6614. Mcgoldrick is affiliated with the MaineHealth Accountable Care Organization (ACO ID: A1290), Community Care Partnership of Maine, LLC (ACO ID: A2831), and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Mcgoldrick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 375 traditional Medicare patients, billed 982 HCPCS/CPT codes, and received $118,495 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 531 prescription claims across 146 beneficiaries totaling $176,277 in drug costs, led by Thiola Ec (Tiopronin). DME data shows 119 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $182,214 to $118,495. Similarly, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $326,173 to $176,277. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	591	1,993	$182,214
2016	605	1,896	$191,108
2017	634	1,964	$222,699
2018	616	1,676	$188,176
2019	595	2,004	$213,325
2020	547	1,880	$212,107
2021	525	1,755	$224,692
2022	457	1,358	$149,789
2023	373	979	$103,678
2024	375	982	$118,495

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	202	1,429	$326,173
2016	205	1,373	$287,890
2017	215	1,289	$252,878
2018	198	962	$127,971
2019	169	837	$115,408
2020	175	863	$100,205
2021	178	794	$103,503
2022	166	646	$119,425
2023	139	548	$172,901
2024	146	531	$176,277

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	131	$4,860
2019	N/R	157	$6,407
2020	N/R	164	$3,831
2021	N/R	130	$2,833
2022	N/R	100	$5,077
2023	N/R	101	$5,064
2024	N/R	119	$1,659

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	100	179	$261
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	63	77	$217
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	109	141	$80
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	110	347	$57
90935	Hemodialysis procedure with physician evaluation	31	71	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Thiola Ec	Tiopronin	12	360	$60,676
Velphoro	Sucroferric Oxyhydroxide	13	570	$36,278
Sevelamer Carbonate	Sevelamer Carbonate	54	2,464	$10,796
Lokelma	Sodium Zirconium Cyclosilicate	20	655	$10,356
Sps	Sodium Polystyrene Sulfon/Sorb	13	545	$5,257

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	30	$565
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	33	$502
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	25	$396
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	15	$185
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	16	$12

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Michael C. Mcgoldrick, MD?

Tedicare shows public-source Medicare data for Michael C. Mcgoldrick, MD (NPI 1285749085), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael C. Mcgoldrick, MD have ACO affiliation data?

Michael C. Mcgoldrick, MD is shown with ACO affiliation data for MaineHealth Accountable Care Organization (MSSP, ACO ID A1290), Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831), and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Michael C. Mcgoldrick, MD?

Michael C. Mcgoldrick, MD is linked to NORTHEAST NEPHROLOGY PA (billing NPI 1336145200) in the available physician profile data.

Does Michael C. Mcgoldrick, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.